These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33463844)

  • 1. Application of online liquid chromatography/quadrupole time-of-flight electrospray ionization tandem mass spectrometry for structural characterization of linagliptin degradation products and related impurities.
    Yadav AS; Dornala D; Swain D; Prabha A; Samanthula G
    Rapid Commun Mass Spectrom; 2020 Nov; 34(21):e8874. PubMed ID: 33463844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analytical method development, identification, and characterization of stress degradation products of idelalisib by ultrahigh-performance liquid chromatography with photodiode array and ultrahigh-performance liquid chromatography with electrospray ionization quadrupole time-of-flight mass spectrometry studies.
    Mahesh M; Bali A; Gupta T
    Rapid Commun Mass Spectrom; 2024 Jun; 38(11):e9745. PubMed ID: 38591150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability-indicating assay method for acotiamide: Separation, identification and characterization of its hydroxylated and hydrolytic degradation products along with a process-related impurity by ultra-high-performance liquid chromatography/electrospray ionization quadrupole time-of-flight tandem mass spectrometry.
    Thummar M; Patel PN; Samanthula G; Ragampeta S
    Rapid Commun Mass Spectrom; 2017 Nov; 31(21):1813-1824. PubMed ID: 28836303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of degradation products of brivaracetam using liquid chromatography quadrupole time-of-flight tandem mass spectrometry: Degradation pathway elucidation.
    Xu K; Ning M; Li W; Dong H; Lu Y; Hang T; Song M
    Rapid Commun Mass Spectrom; 2024 Jan; 38(2):e9651. PubMed ID: 38124167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Forced degradation study of baricitinib and structural characterization of its degradation impurities by high-resolution mass spectrometry and nuclear magnetic resonance spectroscopy.
    Chaganti S; Dhiman V; Madhyanapu Golla V; K R R; Khemchandani R; Samanthula G
    Rapid Commun Mass Spectrom; 2023 Sep; 37(18):e9605. PubMed ID: 37580847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of forced degradation products of tamsulosin using liquid chromatography/electrospray ionization tandem mass spectrometry.
    Namdev D; Borkar RM; Raju B; Kalariya PD; Rahangdale VT; Gananadhamu S; Srinivas R
    J Pharm Biomed Anal; 2014 Jan; 88():245-55. PubMed ID: 24083958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification, characterisation and in silico ADMET prediction of ozenoxacin and its degradation products using high-performance liquid chromatography-photodiode array and liquid chromatography-quadrupole time-of-flight-tandem mass spectrometry.
    Matta A; Sundararajan R
    Rapid Commun Mass Spectrom; 2024 Feb; 38(3):e9676. PubMed ID: 38211348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liquid chromatography/electrospray ionization tandem mass spectrometry study of repaglinide and its forced degradation products.
    Purna Chander C; Raju B; Ramesh M; Shankar G; Srinivas R
    Rapid Commun Mass Spectrom; 2018 Aug; 32(15):1181-1190. PubMed ID: 29723439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Forced degradation and impurity profiling: recent trends in analytical perspectives.
    Jain D; Basniwal PK
    J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of seven new related impurities and forced degradation products of tetracaine hydrochloride and proposal of degradation pathway by UHPLC-Q-TOF-MS.
    Liu C; Luo Y; Tao Q; Hong L; Zeng S
    J Pharm Biomed Anal; 2023 Jan; 223():115116. PubMed ID: 36343535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective separation and characterization of the stress degradation products of ondansetron hydrochloride by liquid chromatography with quadrupole time-of-flight mass spectrometry.
    Talluri MV; Keshari KK; Kalariya PD; Srinivas R
    J Sep Sci; 2015 May; 38(10):1625-32. PubMed ID: 25727389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and Structural Characterization of Degradation Products of Linagliptin by Mass Spectrometry Techniques.
    Liana A; Hałuszczuk A; Gawor A; Bulska E
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation, Characterization, and Toxicity Study of Stress Degradation Products of Pranlukast Hydrate.
    Prajapati KJ; Kothari CS
    Chem Res Toxicol; 2022 Jul; 35(7):1206-1219. PubMed ID: 35731702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical practical aspects in the application of liquid chromatography-mass spectrometric studies for the characterization of impurities and degradation products.
    Narayanam M; Handa T; Sharma P; Jhajra S; Muthe PK; Dappili PK; Shah RP; Singh S
    J Pharm Biomed Anal; 2014 Jan; 87():191-217. PubMed ID: 23706957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of degradation products of saquinavir mesylate by ultra-high-performance liquid chromatography/electrospray ionization quadrupole time-of-flight tandem mass spectrometry and its application to quality control.
    Thummar M; Patel PN; Petkar AL; Swain D; Srinivas R; Samanthula G
    Rapid Commun Mass Spectrom; 2017 May; 31(9):771-781. PubMed ID: 28233930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liquid chromatography/tandem mass spectrometry study of forced degradation of azilsartan medoxomil potassium.
    Swain D; Patel PN; Palaniappan I; Sahu G; Samanthula G
    Rapid Commun Mass Spectrom; 2015 Aug; 29(15):1437-47. PubMed ID: 26147484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective separation and characterisation of stress degradation products and process impurities of prucalopride succinate by LC-QTOF-MS/MS.
    Mahamuni BS; Jajula A; Awasthi A; Kalariya PD; Talluri MV
    J Pharm Biomed Anal; 2016 Jun; 125():219-28. PubMed ID: 27037978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of degradation products of macitentan under various stress conditions using liquid chromatography/mass spectrometry.
    Yerra NV; Pallerla P; Pandeti S; Tabet JC; Thota JR
    Rapid Commun Mass Spectrom; 2018 Jul; 32(13):1075-1084. PubMed ID: 29660192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of hydrolytic and isomeric N-oxide degradants of vilazodone by on line LC-ESI-MS/MS and APCI-MS.
    Kalariya PD; Talluri MV; Patel PN; Srinivas R
    J Pharm Biomed Anal; 2015 Jan; 102():353-65. PubMed ID: 25459935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of degradation products and process-related impurity of sutezolid by liquid chromatography/electrospray ionization tandem mass spectrometry.
    Guo K; Zhang T; Wang Y; Jin B; Ma C
    J Pharm Biomed Anal; 2019 May; 169():196-207. PubMed ID: 30877931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.